Compare OCS & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCS | CBL |
|---|---|---|
| Founded | 2003 | 1978 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | 1993 |
| Metric | OCS | CBL |
|---|---|---|
| Price | $21.14 | $37.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $39.80 | ★ $45.00 |
| AVG Volume (30 Days) | 100.6K | ★ 169.7K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | N/A | ★ 297.30 |
| EPS | N/A | ★ 4.02 |
| Revenue | $991,999.00 | ★ $553,643,000.00 |
| Revenue This Year | $35.00 | N/A |
| Revenue Next Year | $874.12 | N/A |
| P/E Ratio | ★ N/A | $9.51 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $14.00 | $21.10 |
| 52 Week High | $23.08 | $38.67 |
| Indicator | OCS | CBL |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 74.23 |
| Support Level | $19.12 | $37.32 |
| Resistance Level | $21.86 | $38.67 |
| Average True Range (ATR) | 0.73 | 0.76 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 75.93 | 80.37 |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.